The Garvan Institute of Medical Research announces the launch of spin-off company Solvanix Pty Ltd, set up to commercialise a novel technology that will improve the stability of therapeutic monoclonal antibodies.
from The Medical News http://ift.tt/1sJtbJ3
from The Medical News http://ift.tt/1sJtbJ3
No comments:
Post a Comment